These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 6222110)
21. Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8. Kansas GS; Wood GS; Fishwild DM; Engleman EG J Immunol; 1985 May; 134(5):2995-3002. PubMed ID: 3156924 [TBL] [Abstract][Full Text] [Related]
22. Antileukemia activity of a natural killer cell line against human leukemias. Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753 [TBL] [Abstract][Full Text] [Related]
23. Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells. van de Griend RJ; van Krimpen BA; Ronteltap CP; Bolhuis RL J Immunol; 1984 Jun; 132(6):3185-91. PubMed ID: 6233369 [TBL] [Abstract][Full Text] [Related]
24. Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells. Itoh K; Tilden AB; Kumagai K; Balch CM J Immunol; 1985 Feb; 134(2):802-7. PubMed ID: 3917475 [TBL] [Abstract][Full Text] [Related]
25. Production of B cell growth factor by a Leu-7+, OKM1+ non-T cell with the features of large granular lymphocytes (LGL). Pistoia V; Cozzolino F; Torcia M; Castigli E; Ferrarini M J Immunol; 1985 May; 134(5):3179-84. PubMed ID: 3920315 [TBL] [Abstract][Full Text] [Related]
26. Correlation of natural killer cell function with Leu 7 reactivity in patients with humoral immunodeficiency. Huwyler T; Morell A; Hirt A; Ricci C; Wagner HP; Barandun S Clin Exp Immunol; 1984 Jun; 56(3):486-92. PubMed ID: 6744658 [TBL] [Abstract][Full Text] [Related]
27. Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors. Damle NK; Doyle LV; Bradley EC J Immunol; 1986 Nov; 137(9):2814-22. PubMed ID: 2944965 [TBL] [Abstract][Full Text] [Related]
28. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells. Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733 [TBL] [Abstract][Full Text] [Related]
29. The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes. Thiele DL; Lipsky PE J Immunol; 1986 Feb; 136(3):1038-48. PubMed ID: 2934477 [TBL] [Abstract][Full Text] [Related]
30. Preservation of natural killer and interleukin-2 activated killer cell activity in ataxia-telangiectasia with T cell deficiency. Tsuge I; Matsuoka H; Torii S; Okada J; Mizuno T; Matsuoka M; Kodera Y; Takahashi T J Clin Lab Immunol; 1987 May; 23(1):7-13. PubMed ID: 3497277 [TBL] [Abstract][Full Text] [Related]
31. Multiparameter immunologic studies in patients with newly diagnosed type 1 insulin-dependent diabetes mellitus. Gupta S; Charles MA; Waldeck N; Kershnar A; Buckingham B Diabetes Res; 1986 Jun; 3(5):225-9. PubMed ID: 2943547 [TBL] [Abstract][Full Text] [Related]
32. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals. Robertson MJ; Cameron C; Lazo S; Cochran KJ; Voss SD; Ritz J Nat Immun; 1996-1997; 15(5):213-26. PubMed ID: 9390270 [TBL] [Abstract][Full Text] [Related]
34. Generation of NK cell activity from human bone marrow. Lotzová E; Savary CA J Immunol; 1987 Jul; 139(1):279-84. PubMed ID: 3495600 [TBL] [Abstract][Full Text] [Related]
35. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation. Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930 [TBL] [Abstract][Full Text] [Related]
36. Characterization of human granular lymphocyte subpopulations expressing HNK-1 (Leu-7) and Leu-11 antigens in the blood and lymphoid tissues from fetuses, neonates and adults. Abo T; Miller CA; Balch CM Eur J Immunol; 1984 Jul; 14(7):616-23. PubMed ID: 6430709 [TBL] [Abstract][Full Text] [Related]
37. In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2. McMannis JD; Fisher RI; Creekmore SP; Braun DP; Harris JE; Ellis TM J Immunol; 1988 Feb; 140(4):1335-40. PubMed ID: 3257776 [TBL] [Abstract][Full Text] [Related]
38. Adherent lymphokine-activated natural killer cells in normal and severe combined immunodeficiency mice: large granular lymphocytes with natural killer cell phenotype and high cytolytic activity. Chang HL; Zaroukian MH; Morrison MH; Esselman WJ Nat Immun Cell Growth Regul; 1989; 8(2):89-99. PubMed ID: 2788243 [TBL] [Abstract][Full Text] [Related]
39. T cell receptor genes do not rearrange or express functional transcripts in natural killer cells of scid mice. Tutt MM; Schuler W; Kuziel WA; Tucker PW; Bennett M; Bosma MJ; Kumar V J Immunol; 1987 Apr; 138(7):2338-44. PubMed ID: 3559207 [TBL] [Abstract][Full Text] [Related]
40. Acquisition of suppressive activity and natural killer-like cytotoxicity by human alloproliferative "helper" T cell clones. Pawelec G; Schneider EM; Wernet P J Immunol; 1986 Jan; 136(2):402-11. PubMed ID: 2934470 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]